In re Dow Chem. Co. Derivative Litig., 2010 WL 66769 (Del. Ch. 2010)
In re Dow Chemical Co. Derivative Litigation represents a pivotal moment in the realm of corporate governance.
Did Dow Chemical Company's board of directors breach their fiduciary duties by failing to adequately manage the risks associated with the acquisition of Rohm and Haas Company?
Corporate directors have fiduciary duties of care, loyalty, and good faith. The duty of care requires directors to make informed decisions and assess risks diligently. The business judgment rule generally shields directors' decisions if they are made in good faith, informed, and with the belief that they are in the corporation's best interests.
The Delaware Court of Chancery held that the plaintiffs failed to prove that the board of directors breached their fiduciary duties. The court found that the directors were entitled to the protection of the business judgment rule.
This case is significant for its reinforcement of the business judgment rule, serving as a safeguard for directors against unfounded allegations of duty breaches. It encourages directors to engage with robust decision-making processes while assuring that genuine business judgments, made under challenging circumstances, will be legally protected. Law students studying corporate governance will gain insights into how courts evaluate directors' fiduciary duties amid substantial financial risks.